Epilepsy, a common multifactorial neurological disease, affects about 69 million people
worldwide constituting nearly 1% of the world population. Despite decades of extensive research …

The brain, one of the most resilient organs of the body is highly enriched in lipid content,
suggesting the essential role of lipids in brain physiological activities. Lipids constitute an …

Epilepsy, a neurological disease characterized by recurrent seizures, is highly heterogeneous
in nature. Based on the prevalence, epilepsy is classified into two types: common and …

Despite the progress made in the development of new antiepileptic drugs (AEDs), poor
response to them is a rising concern in epilepsy treatment. Of several hypotheses explaining …

The adenosine triphosphate (ATP)-binding cassette efflux transporter G2 (ABCG2) was
originally discovered in a multidrug-resistant breast cancer cell line. Studies in the past have …

The human cytochrome P450 1A (CYP1A) subfamily genes, CYP1A1 and CYP1A2,
encoding monooxygenases are critically involved in biotransformation of key endogenous …

Valproic acid (VPA) is a well-established anticonvulsant drug discovered serendipitously
and marketed for the treatment of epilepsy, migraine, bipolar disorder and neuropathic pain. …

Purpose Over expression of ATP-binding cassette transporters is considered one of the major
reasons for non-responsiveness to antiepileptic drugs. Carbamazepine (CBZ), one of first …

Epilepsy is a neurological disorder affecting around 1%–2% of population worldwide and its
treatment includes use of antiepileptic drugs to control seizures. Failure to respond to …

Diabetes mellitus is a chronic metabolic disorder in the endocrine system and characterized
by a varied and complex pathophysiology. World-wide there is a dramatic increase in the …